tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

BeOne Medicines narrows FY25 revenue view to $5.0B-$5.3B from $4.9B-$5.3B

Consensus is for FY25 revenue $5.13B. Reaffirms FY25 GAAP Operating Expenses view $4.1B-$4.4B.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1